2-(1-Methylpropyl)-1-vinylcyclohexyl acetate
Common Name: |
2-(1-Methylpropyl)-1-vinylcyclohexyl acetate |
IUPAC Name: |
(2-butan-2-yl-1-ethenylcyclohexyl) acetate |
Molecular Formula: |
C14H24O2 |
SMILES: |
vCCC(C)C1CCCCC1(C=C)OC(=O)C |
Inchi: |
1S/C14H24O2/c1-5-11(3)13-9-7-8-10-14(13,6-2)16-12(4)15/h6,11,13H,2,5,7-10H2,1,3-4H3 |
Inchi Key: |
KOSQMCNVEGXSCQ-UHFFFAOYSA-N |
Cas No: |
37172-02-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
224.34 |
Mass (g/mol) |
224.178 |
Molar Refractivity |
68.15 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
268.00 to 269.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.0187 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.79 |
LogP |
3.711 |
iLOGP |
3.13 |
XLOGP3 |
4.13 |
WLOGP |
3.71 |
MLOGP |
3.19 |
ESOL Log S |
-3.50 |
ESOL Solubility (mg/ml) |
0.071 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.39 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.06 |
Silicos-IT Solubility (mg/ml) |
0.19 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.74 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.016 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.005 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |